Dr Thuy Le

Dr. Thuy Le is an Associate Professor of Medicine at Duke University and a Visiting Fellow at the Oxford University Clinical Research Unit in Vietnam. She provides infectious disease consultations for the general infectious disease services at Duke University Medical Center. She leads a research program to reduce HIV-related morbidity and mortality in Southeast Asia by mitigating HIV drug resistance development and developing novel diagnostics and treatment strategies for a leading opportunistic infection caused by the Southeast Asian fungus Talaromyces marneffei. She led the first randomized controlled trial in talaromycosis treatment demonstrating the superiority of amphotericin B over itraconazole which has redefined international treatment recommendations for this important endemic mycosis. She is a Member of the Program Committee for the Asia Pacific AIDS and Co-Infection Conference, Member of several WHO Guidelines Committees on Management of HIV, Member of the NIH/CDC/HIVMA/IDSA Guidelines Committee on Opportunistic Infections, and Coordinator of the European Confederation of Medical Mycology Guidelines for Endemic Mycoses. She has published in the Lancet, Lancet Infectious Diseases, New England Journal of Medicine, Clinical Infectious Diseases, AIDS, and Antiviral Therapy.

Areas of expertise is HIV and medical mycology.